Buprenorphine

Major

Buprenorphine Amphetamine Dexedrine Explained An increased risk of serotonin syndrome Details Buprenorphine Amprenavir Explained Increased buprenorphine exposure and an increased risk of buprenorphine-related adverse events Details Buprenorphine Anagrelide Agrylin An increased risk of QT interval prolongation Details Buprenorphine Anileridine Explained An increased risk of serotonin syndrome and an increased risk of respiratory and CNS depression Details Buprenorphine Apalutamide Erleada Explained Reduced buprenorphine exposure and reduced efficacy of buprenorphine Details Buprenorphine Apomorphine Apokyn Explained An increased risk of QT interval prolongation Details Buprenorphine Aprepitant Aponvie Explained Increased buprenorphine exposure and an increased risk of buprenorphine-related adverse events Details Buprenorphine Aripiprazole Abilify Explained An increased risk of QT interval prolongation and an increased risk of CNS and respiratory depression Details Buprenorphine Aripiprazole Lauroxil Aristada Explained An increased risk of QT interval prolongation and an increased risk of CNS and respiratory depression Details Buprenorphine Armodafinil Nuvigil Explained Reduced buprenorphine exposure and reduced efficacy of buprenorphine Details Buprenorphine Arsenic Trioxide Trisenox Explained An increased risk of QT interval prolongation Details Buprenorphine Artemether Explained An increased risk of QT interval prolongation, reduced CYP3A4 substrates exposure and reduced efficacy of CYP3A4 substrates Details Buprenorphine Asenapine Saphris Explained An increased risk of QT interval prolongation and an increased risk of CNS and respiratory depression Details Buprenorphine Astemizole Explained An increased risk of QT interval prolongation Details Buprenorphine Atazanavir Reyataz Explained An increased risk of QT interval prolongation, increased buprenorphine exposure, an increased risk of buprenorphine-related advers... Details Buprenorphine Atropine Atropen Explained An increased risk of paralytic ileus Details Buprenorphine Avacopan Tavneos Explained Increased CYP3A4 substrate exposure Details Buprenorphine Azithromycin AzaSite Explained An increased risk of QT interval prolongation Details Buprenorphine Baclofen Fleqsuvy Explained Enhanced neuromuscular blocking action and an increased risk of respiratory depression and CNS depression Details Buprenorphine Bedaquiline Sirturo An increased risk of QT interval prolongation Details Buprenorphine Belladonna Explained An increased risk of paralytic ileus Details Buprenorphine Bemetizide Explained Reduced efficacy of diuretics Details Buprenorphine Bendroflumethiazide Explained Reduced efficacy of diuretics Details Buprenorphine Benperidol Explained An increased risk of respiratory depression and CNS depression Details Buprenorphine Bentazepam Explained An increased risk of CNS depression and respiratory depression Details Buprenorphine Benzhydrocodone Explained Reduced analgesic effect or precipitation of withdrawal symptoms, and an increased risk of serotonin syndrome Details Buprenorphine Benzphetamine Explained An increased risk of serotonin syndrome Details Buprenorphine Benzthiazide Explained Reduced efficacy of diuretics Details Buprenorphine Benztropine Explained An increased risk of paralytic ileus Details Buprenorphine Biperiden Explained An increased risk of paralytic ileus Details Buprenorphine Boceprevir Explained Increased buprenorphine exposure and an increased risk of buprenorphine-related adverse events Details Buprenorphine Bosentan Explained Reduced buprenorphine exposure and reduced efficacy of buprenorphine Details Buprenorphine Bromazepam Explained An increased risk of CNS depression and respiratory depression Details Buprenorphine Bromopride Explained Potentiation of sedative effects Details Buprenorphine Brompheniramine Respa-BR Explained An increased risk of serotonin syndrome and an increased risk of paralytic ileus Details Buprenorphine Bumetanide Bumex Explained Reduced efficacy of diuretics Details Buprenorphine Bupropion Aplenzin Explained Increased risk of seizures Details Buprenorphine Buserelin Explained An increased risk of QT interval prolongation Details Buprenorphine Buspirone Bucapsol Explained An increased risk of serotonin syndrome and an increased risk of respiratory and CNS depression Details Buprenorphine Butabarbital Explained An increased risk of respiratory depression and CNS depression Details